Document Detail

Pulmonary tumor thrombotic microangiopathy in patients with gastric carcinoma: an analysis of 6 autopsy cases and review of the literature.
MedLine Citation:
PMID:  20554399     Owner:  NLM     Status:  MEDLINE    
Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare clinicopathological entity causing severe pulmonary hypertension (PH). Its histological features include widespread tumor emboli of the small arteries and arterioles of the lung, associated with thrombus formation and fibrocellular and fibromuscular intimal proliferation. Although PTTM has drawn increased attention as a fatal complication of gastric carcinoma (GC), comprehensive studies are still lacking. In order to clarify clinical and pathological features of GC-induced PTTM, recent autopsy cases were analyzed with a review of the literature. Of 36 autopsy cases with GC, 6 (16.7%) were affected by PTTM. Four were male and 2 female, with a mean age of 72.7 years. Three patients presented with PTTM-related clinical manifestations and died of PTTM. They showed clear morphological evidence of PH. The other 3 patients had PTTM as an incidental finding irrespective of clinical manifestations or PH. No patient was diagnosed antemortem as PTTM. All PTTM cases were associated with advanced GC, with a histology of adenocarcinoma of poorly differentiated type (n=4) or signet-ring cell type (n=2). Expression of tissue factor and vascular endothelial growth factor was confirmed immunohistochemically in tumor cells in all cases. The results were all in line with previous studies. In addition, the current study revealed vascular lesions characteristic of PTTM morphology to be present exclusively in the lung. In conclusion, our study shows a 16.7% incidence of PTTM in GC patients, with half of them developing PH and dying of PTTM, confirming a clinical significance as a non-negligible lethal complication of GC. In addition to many known clinicopathological characteristics of PTTM, the current study pointed to some PTTM issues requiring clarification, including the pathogenesis of the exclusive pulmonary distribution of vascular lesions of PTTM. Since details remain to be elucidated, interdisciplinary research is a high priority with a close collaboration between pathologists and clinicians in order to overcome this lethal condition.
Katsuya Chinen; Yasuharu Tokuda; Masachika Fujiwara; Yasunori Fujioka
Related Documents :
11431779 - Primary pulmonary rhabdomyosarcoma arising within cystic adenomatoid malformation: a ca...
22028569 - Solitary type of congenital self-healing reticulohistiocytosis.
22985409 - Analysis of malaria surveillance data in ethiopia: what can be learned from the integra...
14872299 - Scimitar vein draining to the left atrium and a historical review of the scimitar syndr...
23827449 - Thoraco-omphalopagus asymmetric conjoined twins: report of a case and complete review o...
17117319 - Recurrent episodes of dermatomyositis-associated pneumonitis masquerading as hypersensi...
15667489 - Pyogenic liver abscess with a focus on klebsiella pneumoniae as a primary pathogen: an ...
22747929 - Laptop-induced erythema ab igne: report and review of literature.
24932889 - Psoriatic arthritis and nail changes: exploring the relationship.
Publication Detail:
Type:  Journal Article; Review     Date:  2010-06-15
Journal Detail:
Title:  Pathology, research and practice     Volume:  206     ISSN:  1618-0631     ISO Abbreviation:  Pathol. Res. Pract.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-11     Completed Date:  2011-02-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7806109     Medline TA:  Pathol Res Pract     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  682-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier GmbH. All rights reserved.
Department of Pathology, Kyorin University School of Medicine, Mitaka-city, Tokyo 181-8611, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenocarcinoma / chemistry,  complications,  mortality,  secondary*
Aged, 80 and over
Carcinoma, Signet Ring Cell / chemistry,  complications,  mortality,  secondary*
Cell Differentiation
Hypertension, Pulmonary / etiology,  pathology
Lung Neoplasms / chemistry,  complications,  secondary*
Middle Aged
Neoplastic Cells, Circulating / chemistry,  pathology*
Stomach Neoplasms / pathology*
Thromboplastin / analysis
Thrombotic Microangiopathies / etiology,  metabolism,  mortality,  pathology*
Vascular Endothelial Growth Factor A / analysis
Reg. No./Substance:
0/VEGFA protein, human; 0/Vascular Endothelial Growth Factor A; 9035-58-9/Thromboplastin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of weaning status on lipids of Galician Blond veal: total fatty acids and 18:1 cis and trans ...
Next Document:  Assessment of addiction severity among ritual users of ayahuasca.